共 33 条
[1]
Al-Futaisi A., Al-Zakwani I., Almahrezi A., Et al., Prevalence and predictors of microalbuminuria in patients with type 2 diabetes mellitus: A cross-sectional observational study in Oman, Diabetes Res Clin Pract, 72, pp. 212-215, (2005)
[2]
Bakris G.L., Fonseca V., Katholi R.E., Et al., Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes, Hypertension, 46, pp. 1309-1315, (2005)
[3]
Barnett A.H., Bain S.C., Bouter P., Et al., Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy, N Engl J Med, 351, pp. 1952-1961, (2004)
[4]
Bohlender J.M., Franke S., Stein G., Wolf G., Advanced glycation end products and the kidney, Am J Physiol Renal Physiol, 289, pp. 645-659, (2005)
[5]
Cao J.J., Barzilay J.I., Peterson D., Et al., The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: The cardiovascular health study, Atherosclerosis, (2005)
[6]
Cederholm J., Eliasson B., Nilsson P.M., Et al., Microalbuminuria and riskfactors in type 1 and type 2 diabetic patients, Diabetes Res Clin Pract, 67, pp. 258-266, (2005)
[7]
Gaede P., Vedel P., Larsen N., Et al., Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, N Engl J Med, 348, pp. 383-393, (2003)
[8]
Gerstein H.C., Mann J.F., Yi Q., Et al., Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals, JAMA, 286, pp. 421-426, (2001)
[9]
Hillege H.L., Fidler V., Diercks G.F., Et al., Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population, Circulation, 106, pp. 1777-1782, (2002)
[10]
Kramer H., Molitch M.E., Screening for kidney disease in adults with diabetes, Diabetes Care, 28, pp. 1813-1816, (2005)